Our results revealed that, contrary to the findings for ADIPOQ (an insulin sensitizer), the levels of circulating CTRP7 were markedly increased in individuals with IGT and T2DM. This evidence concerns the gene C1QTNF7 and type 2 diabetes mellitus.